90.08MMarket Cap-0.81P/E (TTM)
1.050High0.967Low908.77KVolume0.967Open0.957Pre Close922.22KTurnover1.75%Turnover RatioLossP/E (Static)90.08MShares2.11052wk High2.18P/B51.99MFloat Cap0.92052wk Low--Dividend TTM51.99MShs Float28.990Historical High--Div YieldTTM8.69%Amplitude0.920Historical Low1.014Avg Price1Lot Size
Immunic Stock Forum
Immunic Highlights 2024 Accomplishments and Upcoming Milestones
Tuesday, 7th January at 6:30 am
– Top-Line Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis Expected in April –
– Reported Positive Outcome from Interim Analysis of Ongoing, Twin Phase 3 ENSURE Trials of Vidofludimus Calcium in Relapsing Multiple Sclerosis; Both Trials on Track to Be Completed in 2026 –
– Strengthened Management Team and Board of Directors with Key Hir...
Anything Important?
No comment yet